van Oijen MGH - Search Results

1

Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials.

Belkouz A, Wilmink JW, Haj Mohammad N, Hagendoorn J, de Vos-Geelen J, Dejong CHC, Homs MYV, Groot Koerkamp B, van Gulik TM, van Oijen MGH, Punt CJA, Klümpen H. Belkouz A, et al. Among authors: van oijen mgh, van gulik tm. Crit Rev Oncol Hematol. 2020 Jul;151:102975. doi: 10.1016/j.critrevonc.2020.102975. Epub 2020 Apr 27. Crit Rev Oncol Hematol. 2020. PMID: 32464483 Free article. Review.

2

Changes in diagnostic and treatment strategies of oesophageal cancer in the period from 2001 to 2009: a survey in the Netherlands.

Homs MY, van Oijen MG, Wijnhoven BP, van Hillegersberg R, de Boer-Dennert M, Siersema PD. Homs MY, et al. Eur J Gastroenterol Hepatol. 2012 Feb;24(2):126-33. doi: 10.1097/MEG.0b013e32834e7f29. Eur J Gastroenterol Hepatol. 2012. PMID: 22113210

3

Burden of spousal caregivers of stage II and III esophageal cancer survivors 3 years after treatment with curative intent.

Haj Mohammad N, Walter AW, van Oijen MG, Hulshof MC, Bergman JJ, Anderegg MC, van Berge Henegouwen MI, Henselmans I, Sprangers MA, van Laarhoven HW. Haj Mohammad N, et al. Support Care Cancer. 2015 Dec;23(12):3589-98. doi: 10.1007/s00520-015-2727-4. Epub 2015 Apr 18. Support Care Cancer. 2015. PMID: 25894882 Free PMC article.

4

Surveillance for hepatocellular carcinoma is associated with increased survival: Results from a large cohort in the Netherlands.

van Meer S, de Man RA, Coenraad MJ, Sprengers D, van Nieuwkerk KM, Klümpen HJ, Jansen PL, IJzermans JN, van Oijen MG, Siersema PD, van Erpecum KJ. van Meer S, et al. J Hepatol. 2015 Nov;63(5):1156-63. doi: 10.1016/j.jhep.2015.06.012. Epub 2015 Jun 20. J Hepatol. 2015. PMID: 26100498

5

Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better Outcomes.

Spierings LE, Lagarde SM, van Oijen MG, Gisbertz SS, Wilmink JW, Hulshof MC, Meijer SL, Anderegg MC, van Berge Henegouwen MI, van Laarhoven HW. Spierings LE, et al. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S766-71. doi: 10.1245/s10434-015-4850-3. Epub 2015 Sep 8. Ann Surg Oncol. 2015. PMID: 26350367

6

Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer.

Bos AC, van Erning FN, van Gestel YR, Creemers GJ, Punt CJ, van Oijen MG, Lemmens VE. Bos AC, et al. Eur J Cancer. 2015 Nov;51(17):2553-61. doi: 10.1016/j.ejca.2015.08.016. Epub 2015 Sep 7. Eur J Cancer. 2015. PMID: 26360411

7

ABC-Transporter Expression Does Not Correlate with Response to Irinotecan in Patients with Metastatic Colorectal Cancer.

Trumpi K, Emmink BL, Prins AM, van Oijen MG, van Diest PJ, Punt CJ, Koopman M, Kranenburg O, Rinkes IH. Trumpi K, et al. J Cancer. 2015 Sep 3;6(11):1079-86. doi: 10.7150/jca.12606. eCollection 2015. J Cancer. 2015. PMID: 26516354 Free PMC article.

8

Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature.

Ter Veer E, Haj Mohammad N, van Valkenhoef G, Ngai LL, Mali RM, van Oijen MG, van Laarhoven HW. Ter Veer E, et al. Cancer Metastasis Rev. 2016 Sep;35(3):439-56. doi: 10.1007/s10555-016-9632-2. Cancer Metastasis Rev. 2016. PMID: 27417221 Free PMC article. Review.

9

Prospective Dutch colorectal cancer cohort: an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research.

Burbach JP, Kurk SA, Coebergh van den Braak RR, Dik VK, May AM, Meijer GA, Punt CJ, Vink GR, Los M, Hoogerbrugge N, Huijgens PC, Ijzermans JN, Kuipers EJ, de Noo ME, Pennings JP, van der Velden AM, Verhoef C, Siersema PD, van Oijen MG, Verkooijen HM, Koopman M. Burbach JP, et al. Acta Oncol. 2016 Nov;55(11):1273-1280. doi: 10.1080/0284186X.2016.1189094. Epub 2016 Aug 25. Acta Oncol. 2016. PMID: 27560599

10

The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis.

Ter Veer E, Haj Mohammad N, van Valkenhoef G, Ngai LL, Mali RMA, Anderegg MC, van Oijen MGH, van Laarhoven HWM. Ter Veer E, et al. Among authors: van oijen mgh, van laarhoven hwm, van valkenhoef g. J Natl Cancer Inst. 2016 Aug 30;108(10). doi: 10.1093/jnci/djw166. Print 2016 Oct. J Natl Cancer Inst. 2016. PMID: 27576566 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters